136 related articles for article (PubMed ID: 21070576)
1. Extranodal extension in node-positive bladder cancer: the continuing controversy.
Jeong IG; Ro JY; Kim SC; You D; Song C; Hong JH; Ahn H; Kim CS
BJU Int; 2011 Jul; 108(1):38-43. PubMed ID: 21070576
[TBL] [Abstract][Full Text] [Related]
2. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
[TBL] [Abstract][Full Text] [Related]
3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Steven K; Poulsen AL
J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
[TBL] [Abstract][Full Text] [Related]
4. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
Wright JL; Lin DW; Porter MP
Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
[TBL] [Abstract][Full Text] [Related]
5. Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Hellenthal NJ; Hussain A; Andrews PE; Carpentier P; Castle E; Dasgupta P; Kaouk J; Khan S; Kibel A; Kim H; Manoharan M; Menon M; Mottrie A; Ornstein D; Palou J; Peabody J; Pruthi R; Richstone L; Schanne F; Stricker H; Thomas R; Wiklund P; Wilding G; Guru KA
BJU Int; 2011 Feb; 107(4):642-6. PubMed ID: 20575975
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the new American Joint Committee on Cancer substratification in node-negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series.
Gakis G; Schilling D; Renninger M; Seibold J; Sievert KD; Stenzl A
BJU Int; 2011 Mar; 107(6):919-23. PubMed ID: 21392208
[TBL] [Abstract][Full Text] [Related]
7. Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology.
Baltaci S; Adsan O; Ugurlu O; Aslan G; Can C; Gunaydin G; Buyukalpelli R; Elhan AH; Beduk Y
BJU Int; 2011 Feb; 107(4):547-53. PubMed ID: 20633004
[TBL] [Abstract][Full Text] [Related]
8. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
9. Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed.
Jeong IG; Park J; Song K; Ro JY; Song C; Hong JH; Ahn H; Kim CS
Urol Oncol; 2011; 29(2):199-204. PubMed ID: 19556153
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial.
Bolenz C; Herrmann E; Bastian PJ; Michel MS; Wülfing C; Tiemann A; Buchner A; Stief CG; Fritsche HM; Burger M; Wieland WF; Höfner T; Haferkamp A; Hohenfellner M; Müller SC; Ströbel P; Trojan L
BJU Int; 2010 Aug; 106(4):493-9. PubMed ID: 20067452
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF
J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenectomy for bladder cancer: indications and controversies.
Burkhard FC; Roth B; Zehnder P; Studer UE
Urol Clin North Am; 2011 Nov; 38(4):397-405, v. PubMed ID: 22045171
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
Harada K; Sakai I; Hara I; Eto H; Miyake H
Int J Urol; 2005 Mar; 12(3):250-5. PubMed ID: 15828951
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
Kassouf W; Leibovici D; Munsell MF; Dinney CP; Grossman HB; Kamat AM
J Urol; 2006 Jul; 176(1):53-7; discussion 57. PubMed ID: 16753366
[TBL] [Abstract][Full Text] [Related]
17. Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy.
Thompson IM
J Urol; 2001 Aug; 166(2):630. PubMed ID: 11458100
[No Abstract] [Full Text] [Related]
18. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
Ide H; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
[TBL] [Abstract][Full Text] [Related]
19. [Value of computerized tomography in detection of lymph node metastases in bladder cancer].
Buszello H; Müller-Mattheis V; Ackermann R
Urologe A; 1994 May; 33(3):243-6. PubMed ID: 8053093
[TBL] [Abstract][Full Text] [Related]
20. Superiority of ratio based lymph node staging for bladder cancer.
Herr HW
J Urol; 2003 Mar; 169(3):943-5. PubMed ID: 12576818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
